Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludeoxyglucose
Non-Small Cell Lung Carcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(69)
Fludrocortisone
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center
P3
BB
(69)
Fluorouracilum
Peritoneum Cancer
City of Hope Medical Center
P3
BB
(69)
Gilteritinib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow University
P3
BB
(69)
Imatinib
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
The University of Hong Kong
P3
BB
(69)
Irinotecan
Metastatic Malignant Neoplasm
Incyte Corporation
P3
BB
(69)
Irinotecan
Primary Peritoneal Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(69)
Labetalol
Essential Hypertension
ProMedica Health System
P3
BB
(69)
Labetalol
Stroke Disorder
ProMedica Health System
P3
BB
(69)
Lacto-Flavin
Traumatic Brain Injury
POLYSAN Scientific & Technological Pharmaceutical Company
P3
BB
(69)
Lenalidomide
B-Cell Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer Centre
P3
BB
(69)
Memantine
Cognitive Disorder
UNC Lineberger Comprehensive Cancer Center
P3
BB
(69)
Mercaptopurine Anhydrous
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(69)
Methotrexate
Non-Hodgkin Lymphoma
Sun Yat-sen University
P3
BB
(69)
Methotrexate
Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
P3
BB
(69)
Penicillamine
Wilson Disease
Orphalan
P3
BB
(69)
Prednisone
Hodgkins Lymphoma
National Research Center for Hematology, Russia
P3
BB
(69)
Prednisone
Leukemia
Inhye Ahn
P3
BB
(69)
Prednisone
Primary Mediastinal Large B-Cell Lymphoma
University of Washington
P3
BB
(69)
Pridopidine
Huntington Disease
Prilenia
P3
BB
(69)
Procarbazine
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
P3
BB
(69)
Ribociclib
Estrogen-Receptor Positive Breast Cancer
National Cancer Institute (NCI)
P3
BB
(69)
Ribociclib
HER2 Positive Breast Carcinoma
Danish Breast Cancer Cooperative Group
P3
BB
(69)
Rivaroxaban
Patent Foramen Ovale
Chinese Academy of Medical Sciences, Fuwai Hospital
P3
BB
(69)
Tacrolimus
Plasma Cell Myeloma
Thomas Jefferson University
P3
BB
(69)
Showing 1526 to 1550 of 18,153 assets
Previous
Page 62 of 727
Next